Home Products Antibodies Primary Antibodies PIMA110447
PIMA110447

PSA Monoclonal Antibody (A67-B/E3), Biotin, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA110447-Each-of-1 In Stock ₹ 36,757.00

PIMA110447 - Each of 1

₹ 36,757.00

In Stock

Quantity

1

Base Price: ₹ 36,757.00

GST (18%): ₹ 6,616.26

Total Price: ₹ 43,373.26

Antigen

PSA

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 15mM sodium azide; pH 7.4

Gene Accession No.

P07288

Gene Symbols

KLK3

Immunogen

30 KDa protein fraction prepared from human seminal plasma

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Immunohistochemistry (Paraffin), Western Blot

Clone

A67-B/E3

Conjugate

Biotin

Gene

KLK3

Gene Alias

Antigen; antigen, prostate specific; APS; Fletcher factor; gamma-seminoprotein; hK3; Kal3; Kal-3; Kallikrein 3; kallikrein 3, plasma; kallikrein B, plasma 1; kallikrein related peptidase 3; kallikrein-3; Kallikrein-3 (KLK3); kallikrein-related peptidase 3; Kalp1; KALP15; Kininogenin; KLK2A1; Klk3; KLK-3; Klkb1; P-30 antigen; Pk; Plasma kallikrein; Plasma kallikrein heavy chain; Plasma kallikrein light chain; Plasma prekallikrein; prostate specific antigen; prostate-specific (APS); prostate-specific antigen; PSA; Semenogelase; seminin

Host Species

Mouse

Purification Method

Size-exclusion chromatography

Regulatory Status

RUO

Gene ID (Entrez)

354

Content And Storage

4° C, do not freeze

Form

Liquid

Description

  • PSA is a chymotrypsin-like serine protease (kallikrein family) produced by the prostate epithelium, and is abundant in seminal fluid
  • PSA can be detected in the sera of patients with prostatic carcinoma
  • It is predominantly complexed to a liver-derived serine protease inhibitor, alpha-1-antichymotrypsin (ACT)
  • A higher proportion of serum PSA is complexed to ACT in prostate cancer than in benign prostate hyperplasia
  • PSA is used to confirm prostatic acinar cell origin in primary and metastatic carcinoma and to rule out non-prostatic carcinoma mimics.